Centessa Pharmaceuticals plc American Depositary Shares (CNTA) Stock Price

CNTAStock
$0.00+69.17%52W
Market Cap
P/E
PEG Ratio
Div yield
Beta0.26

CNTA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)47.11%
Price vs S&P 500 (4W)4.08%
VGM Score82.56

CNTA Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q1 2026-$0.41-$0.52-28.08%(-$0.11)
Q4 2025-$0.38-$0.48-25.08%(-$0.10)
Q3 2025-$0.39-$0.41-5.73%(-$0.02)
Q2 2025-$0.35-$0.38-9.61%(-$0.03)

CNTA Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.68
3.68
3.68
3.68

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CNTACentessa Pharmaceuticals plc American Depositary Shares
A$0.00
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Centessa Pharmaceuticals plc American Depositary Shares

Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company with a portfolio of therapeutic candidates across multiple disease areas. Key programs include SerpinPC for hemophilia, LB101 for solid tumors, ORX750 for narcolepsy and sleep disorders, and MGX292 for pulmonary arterial hypertension, plus an undisclosed solid tumor program.